Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.
暂无分享,去创建一个
J. Mellors | A. Collier | B. Taiwo | Linda J Harrison | M. Hosseinipour | N. Kumarasamy | C. Wallis | Lu Zheng | Peter S. Kim | A. L. La Rosa | B. Jarocki